You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TMZ

Showing 1 - 25 of 441
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

Withdrawn
  • MGMT-Methylated Glioblastoma
  • Delay of TMZ
  • Standard of Care (SOC) Adjuvant TMZ (no intervention
  • (no location specified)
Aug 5, 2022

Standard Radiotherapy and TMZ Patients With GBM

Not yet recruiting
  • Glioblastoma
  • Glioma, Malignant
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center at Duke University
    Jan 20, 2023

    Glioblastoma, Recurrent Glioblastoma, GBM Trial in Boston (MN-166, Temozolomide)

    Active, not recruiting
    • Glioblastoma
    • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Nov 16, 2022

    Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))

    Recruiting
    • Glioblastoma
    • GBM
    • Suzhou, Jiangsu, China
      Dushu Lake Hospital Affiliated to Soochow University
    Nov 23, 2023

    Glioblastoma, Diffuse Glioma Trial in Worldwide (NMS-03305293 + TMZ, Lomustine)

    Recruiting
    • Glioblastoma
    • Diffuse Glioma
    • Rochester, Minnesota
    • +3 more
    Mar 11, 2022

    Therapeutic Equivalency Trial in Bron, Bordeaux, Marseille (Ped-TMZ)

    Completed
    • Therapeutic Equivalency
    • Bron, Rhône, France
    • +2 more
    Feb 21, 2022

    Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)

    Not yet recruiting
    • Glioblastoma
    • +2 more
    • SonoCloud-9 (SC9)
    • +3 more
    • Chicago, Illinois
    • +7 more
    Jun 5, 2023

    Glioblastoma Trial in Milwaukee (Radiation, Concurrent Chemotherapy (Temozolomide), Adjuvant Chemotherapy (Temozolomide))

    Recruiting
    • Glioblastoma
    • Radiation
    • +2 more
    • Milwaukee, Wisconsin
      Medical College of Wisconsin
    Jul 25, 2022

    Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)

    Recruiting
    • Anaplastic Oligoastrocytoma
    • Glioblastoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 27, 2022

    Colorectal Cancer Trial in New Haven (Temozolomide + Olaparib)

    Active, not recruiting
    • Colorectal Cancer
    • Temozolomide + Olaparib
    • New Haven, Connecticut
      Yale New Haven Hospital
    Aug 17, 2022

    Glioblastoma Multiforme Trial in Cleveland (biological, drug, other, procedure, radiation)

    Active, not recruiting
    • Glioblastoma Multiforme
    • MGMTP140K-encoding retroviral vector
    • +6 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    May 6, 2022

    Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

    Not yet recruiting
    • Newly Diagnosed Glioblastoma
    • (no location specified)
    Feb 13, 2023

    Glioblastoma Trial in Baltimore (Concurrent CRT Period, Post-CRT Period, Adjuvant Period)

    Recruiting
    • Glioblastoma
    • Concurrent CRT Period
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University/Johns Hopkins Hospital
    Mar 2, 2023

    Primary Glioblastoma Trial (AV-GBM-1, Autologous monocytes)

    Not yet recruiting
    • Primary Glioblastoma
    • AV-GBM-1
    • Autologous monocytes
    • (no location specified)
    Dec 14, 2021

    Acral Melanoma Trial (camrelizumab+apatinib+TMZ, camrelizumab+apatinib, camrelizumab)

    Not yet recruiting
    • Acral Melanoma
    • (no location specified)
    Mar 16, 2023

    Glioma of Brain Trial in Orange (Mirtazapine (Remeron))

    Recruiting
    • Glioma of Brain
    • Mirtazapine (Remeron)
    • Orange, California
      UC Irvine Health/Chao Family Comprehensive Cancer Center
    Dec 26, 2022

    Recurrent Glioblastoma Trial in Beijing (Laser interstitial thermal therapy, Temozolomide)

    Active, not recruiting
    • Recurrent Glioblastoma
    • Beijing, China
      Beijing Tiantan Hospital
    Dec 22, 2022

    Glioblastoma Multiforme of Brain Trial in Beijing (Autologous dendritic cells pulsed with multiple neoantigen peptides.,

    Recruiting
    • Glioblastoma Multiforme of Brain
    • Autologous dendritic cells pulsed with multiple neoantigen peptides.
    • Temozolomide adjuvant chemotherapy
    • Beijing, Beijing, China
      Beijing Tiantan Hospital
    Jan 13, 2022

    Glioblastoma Multiforme Trial in Shijia Zhuang (TMZ)

    Recruiting
    • Glioblastoma Multiforme
    • TMZ
    • Shijia Zhuang, Hebei, China
      the Second Hospital of HeBei Medical University
    Oct 18, 2022

    Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

    Active, not recruiting
    • Glioblastoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 30, 2023

    Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

    Not yet recruiting
    • Glioblastoma Multiforme
    • +3 more
    • P140K-MGMT
    • +5 more
    • Bethesda, Maryland
    • +1 more
    Jul 4, 2022

    Primary Glioblastoma, Glioblastoma Multiforme Trial in Worldwide (2-OHOA, TMZ, RT)

    Recruiting
    • Primary Glioblastoma
    • Glioblastoma Multiforme
    • Angers, France
    • +19 more
    Dec 13, 2022

    Newly-diagnosed Glioblastoma Trial in Beijing (CAN008, Placebo)

    Recruiting
    • Newly-diagnosed Glioblastoma
    • Beijing, Beijing, China
      Beijing Tiantan Hospital, Capital Medical University
    Jul 10, 2022

    Diabetic Nephropathies Trial (Trimetazidine)

    Not yet recruiting
    • Diabetic Nephropathies
    • (no location specified)
    Nov 24, 2021

    Glioblastoma Trial in Boston (radiation, biological, drug)

    Recruiting
    • Glioblastoma
    • Radiation Therapy
    • +3 more
    • Boston, Massachusetts
    • +1 more
    May 31, 2022